Facing a challenging diagnosis of metastatic urologic cancer, one of the state’s top communications professionals leans into her job, laughter and love.

The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.

Estrogen-lowering aromatase inhibitors are frequently prescribed to women with ovarian and uterine cancers. New research sheds light on how side effects impact these patients.

An endocrinologist specializing in thyroid cancer and creator of the Hemoglobin A1c test for diabetes reflects on his career, offering advice for aspiring researchers.

University of Michigan research shows the direct correlation between systemic racism and racial health disparities in the United States.

Rare Disease Day is celebrated across the globe to raise awareness about rare diseases and how they impact patients’ lives. Michigan Medicine is working to better understand the mechanisms behind these rare diseases.

Since receiving a rare brain cancer diagnosis, one patient describes how her care plan at Michigan Medicine to treat her oligodendroglioma has helped, and how she is now helping others around her.

The most read stories of 2019 on the Michigan Health blog.

The most read stories of 2019 on the Michigan Health Lab blog.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

A U-M law student, who passed of breast cancer in 2019, is remembered by her family and school in a special way.

A new study finds patients want to provide consent before researchers or hospitals use their medical records for research.

An ovarian cancer diagnosis gave one 26-year-old patient new perspectives on life and adventure.

Michigan Medicine’s Rogel Cancer Center discusses updated recommendations on screening for BRCA1 and BRCA2 genetic mutations.

A Rogel Cancer Center doctor offers tips to help patients leave their oncology appointments understanding their treatment.